8-K: FOXO Technologies Issues Shares for Services and Secures Convertible Note

FOXO Technologies issued shares for services, and secured a convertible note, increasing its outstanding share count.

Summary

• FOXO Technologies reported the issuance of shares of Class A Common Stock for services rendered and the issuance of a convertible promissory note.
• On March 1, 2024, 469,852 shares were issued to Mitchell Silberberg & Knupp LLP (MSK) for services.
• On March 5, 2024, 450,000 shares were issued to Tysadco Partners for corporate development advisory services.
• On March 27, 2024, an additional 41,175 shares were issued to MSK for services.
• On April 28, 2024, the company issued a convertible promissory note for $110,000 and 200,000 shares to LGH Investments, LLC.
• The convertible note has a beneficial ownership limitation of 4.99%.

Sentiment

Score: 4

Explanation: The document details share dilution and a small convertible note, which is not a strong positive signal for investors. The company is using equity to pay for services, which may indicate cash flow issues.

Positives

• The company secured a $110,000 convertible note, providing additional capital.
• The company is utilizing shares to compensate for services, conserving cash.

Negatives

• The issuance of over 1.3 million shares will dilute existing shareholders.
• The convertible note could potentially lead to further dilution if converted.

Risks

• The increased number of outstanding shares could put downward pressure on the stock price.
• The conversion of the promissory note could further dilute existing shareholders.
• The company's reliance on share issuances for services may indicate cash flow challenges.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Management Comments

• The report was signed by Mark White, Interim Chief Executive Officer.

Industry Context

The issuance of shares for services is a common practice for early-stage companies, particularly in the biotech sector, where cash resources may be limited. The use of convertible notes is also a typical method for raising capital.

Comparison to Industry Standards

• Many early-stage biotech companies use equity to compensate advisors and service providers, similar to FOXO's approach with MSK and Tysadco Partners.
• Convertible notes are a common financing tool for companies that are not yet generating significant revenue, similar to the note issued to LGH Investments, LLC.
• The beneficial ownership limitation of 4.99% on the convertible note is a standard provision to prevent a single investor from gaining too much control.

Stakeholder Impact

• Shareholders will experience dilution due to the issuance of new shares.
• Creditors may be impacted by the issuance of a convertible note.

Key Dates

Keywords

share issuance, convertible note, equity securities, dilution, capital raise, FOXO Technologies, shares for services